Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Acura Pharmaceuticals Cash from Operations (Quarterly): 0.191M for Sept. 30, 2021
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.426M |
| September 30, 2021 | 0.191M |
| June 30, 2021 | -0.194M |
| March 31, 2021 | -0.313M |
| December 31, 2020 | -0.08M |
| September 30, 2020 | -0.545M |
| June 30, 2020 | -0.441M |
| March 31, 2020 | 0.347M |
| December 31, 2019 | 0.522M |
| September 30, 2019 | 0.60M |
| June 30, 2019 | -1.341M |
| March 31, 2019 | -0.399M |
| December 31, 2018 | -1.223M |
| September 30, 2018 | -0.751M |
| June 30, 2018 | -0.969M |
| March 31, 2018 | -0.965M |
| December 31, 2017 | -1.622M |
| September 30, 2017 | -2.099M |
| June 30, 2017 | -2.087M |
| March 31, 2017 | 1.298M |
| December 31, 2016 | 1.78M |
| September 30, 2016 | -1.858M |
| June 30, 2016 | -3.563M |
| March 31, 2016 | -1.922M |
| December 31, 2015 | -1.056M |
| Date | Value |
|---|---|
| September 30, 2015 | -2.129M |
| June 30, 2015 | -2.67M |
| March 31, 2015 | 2.167M |
| December 31, 2014 | -2.359M |
| September 30, 2014 | -2.632M |
| June 30, 2014 | -3.073M |
| March 31, 2014 | -2.98M |
| December 31, 2013 | -3.162M |
| September 30, 2013 | -3.118M |
| June 30, 2013 | -4.075M |
| March 31, 2013 | -3.323M |
| December 31, 2012 | -1.838M |
| September 30, 2012 | -1.821M |
| June 30, 2012 | -2.003M |
| March 31, 2012 | -1.376M |
| December 31, 2011 | -1.889M |
| September 30, 2011 | -1.841M |
| June 30, 2011 | 17.61M |
| March 31, 2011 | -1.564M |
| December 31, 2010 | -1.818M |
| September 30, 2010 | -1.126M |
| June 30, 2010 | -0.733M |
| March 31, 2010 | -2.803M |
| December 31, 2009 | -2.708M |
| September 30, 2009 | -2.228M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.341M
Minimum
Jun 2019
0.60M
Maximum
Sep 2019
-0.1527M
Average
-0.194M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.269M |